When did Baxter International report Q2 2025 earnings?

Baxter International (BAX) reported Q2 2025 earnings on July 31, 2025 before market open.

What were Baxter International's Q2 2025 revenue and EPS?

Baxter International reported revenue of $2.8B and diluted EPS of $0.59 for Q2 2025.

Did Baxter International beat estimates in Q2 2025?

Revenue missed the consensus estimate of $2.9B by $65.9M. EPS missed the consensus estimate of $0.60 by $0.01.

How did Baxter International's Q2 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue declined 26.3% from $3.8B a year earlier and diluted EPS declined 13.2% from $0.68.

Where can I find Baxter International's Q2 2025 SEC filings?

You can read the 10-Q periodic report (0001628280-25-037877) directly on SEC EDGAR. The filing index links above go to sec.gov.

Baxter International BAX Q2 2025 earnings

Reported July 31, 2025 · Before market open

Revenue$2.8BMiss by $65.9M Diluted EPS$0.59Miss by $0.01

Revenue estimate$2.9B

EPS estimate$0.60

Next report

Jul 30, 2026 (In 5 days)

Revenue estimate$2.8B

EPS estimate$0.36

Financials

Q2 2025

Income statement

See full

Revenue$2.8B+4.3%

Gross profit$991.0M-3.9%

Operating income$191.0M+6.7%

Net income$91.0M+129%

EPS (diluted)$0.18+130%

Balance sheet

See full

Cash & equivalents$1.7B+7.2%

Total debt$231.0M-98.3%

Total equity$7.3B-4.2%

Total assets$21.0B-20.0%

Cash flow

See full

Operating cash flow$217.0M+88.7%

CapEx$128.3M+15.0%

Free cash flow$83.0M-42.1%

Valuation & ratios

Valuation

as of 06/30/25

See full

Market cap$15.7B-7.9%

Enterprise value$14.24B-50.6%

P/S1.4×-0.2×

Profitability

See full

Gross margin35.3%-4.2pp

Net margin-1.4%-25.0pp

FCF margin4.2%-6.1pp

Returns & leverage

See full

Return on equity-2.1%-39.6pp

Debt / equity0×-1.7×

Current ratio2.3×+0.9×

Segments

By product

See full

Infusion Therapies & Technologies$1.0B-2.0%

Care & Connectivity Solutions$474.0M+4.9%

Injectables & Anesthesia$332.0M-2.6%

Advanced Surgery$296.0M+6.9%

Front Line Care$293.0M-1.0%

By segment

See full

Medical Products & Therapies$1.3B-0.2%

Healthcare Systems & Technologies$767.0M+2.5%

Pharmaceuticals$612.0M+1.7%

Versus estimates

Revenue

Q1 2026$2.7BBeat by $85.5M Q4 2025$3.0BBeat by $149.2M Q3 2025$2.8BBeat by $10.2M

Q2 2025$2.8BMiss by $65.9M

Q1 2025$2.6BBeat by $37.5M Q4 2024$10.6BBeat by $8.0B

Diluted EPS

Q1 2026$0.36Beat by $0.05 Q4 2025$0.44Miss by $0.09 Q3 2025$0.69Beat by $0.09

Q2 2025$0.59Miss by $0.01

Q1 2025$0.55Beat by $0.07 Q4 2024$0.58Beat by $0.05

Ask the moment Baxter International reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Baxter International report Q2 2025 earnings?: Baxter International (BAX) reported Q2 2025 earnings on July 31, 2025 before market open.
What were Baxter International's Q2 2025 revenue and EPS?: Baxter International reported revenue of $2.8B and diluted EPS of $0.59 for Q2 2025.
Did Baxter International beat estimates in Q2 2025?: Revenue missed the consensus estimate of $2.9B by $65.9M. EPS missed the consensus estimate of $0.60 by $0.01.
How did Baxter International's Q2 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue declined 26.3% from $3.8B a year earlier and diluted EPS declined 13.2% from $0.68.
Where can I find Baxter International's Q2 2025 SEC filings?: You can read the 10-Q periodic report (0001628280-25-037877) directly on SEC EDGAR. The filing index links above go to sec.gov.